CAMP-Dependent Protein Kinase (PKA) as a Drug Target: Unlocking the Potential of STK22

Target Name: cAMP-Dependent protein kinase (PKA)

NCBI ID: P5867

cAMP-Dependent protein kinase (PKA)

Other Name(s): STK22 | PKA | PKA C | ATP:protein phosphotransferase (cAMP-dependent) | Protein kinase A

CAMP-Dependent Protein Kinase (PKA) as a Drug Target: Unlocking the Potential of STK22

CAMP-dependent protein kinase (PKA) is a protein that plays a crucial role in cellular signaling. It is a key mediator of various cellular processes, including cell growth, differentiation, and response to stimuli. The STK22 gene is a non-coding RNA molecule that is closely associated with the protein kinase domain of PKAs. It is a potent regulator of cell proliferation and has been implicated in various diseases, including cancer. In this article, we will explore the potential of STK22 as a drug target and its underlying mechanisms.

Structure and Function

PKA is a protein that consists of a catalytic active site, a regulatory domain, and a carboxylic acid terminator. The catalytic active site is the site of the protein-protein interaction that initiates the catalytic cycle. It is a key region that contains a nucleotide-binding oligomerization (NBO) domain, which is responsible for the formation of a nucleotide-protein complex. The NBO domain is responsible for the recruitment of the nucleotide to the active site, where it can interact with other molecules, including DNA-binding proteins.

The regulatory domain of PKAs is responsible for regulating the activity of the protein. It consists of a series of amino acid residues that form a regulatory interaction with the catalytic active site. The most well-known protein-protein interaction in the regulatory domain is the interaction between the protein-protein interaction and the nucleotide-protein interaction.

The carboxylic acid terminator is the final step of the PKA catalytic cycle. It is a critical region that ensures the stability and integrity of the protein.

PKA is involved in various cellular processes, including cell growth, differentiation, and response to stimuli. It is a key regulator of cell proliferation, and it plays a role in the regulation of DNA replication, transcription, and translation. PKA is also involved in the regulation of cell survival and apoptosis, as well as in the regulation of cell-cell and cell-tissue interactions.

PKA has been implicated in various diseases, including cancer. Studies have shown that PKA is often overexpressed or mutated in cancer cells, and that its regulation is disrupted in cancer. PKA has also been shown to be involved in the regulation of pain perception and neurodegenerative diseases.

Drug Targeting

PKA is a promising drug target for various diseases, including cancer. Studies have shown that inhibiting the activity of PKA can lead to the inhibition of cell proliferation and the inhibition of the growth of cancer cells. Additionally, inhibiting PKA has been shown to lead to the disruption of various signaling pathways that are involved in cancer development, including the PI3K/Akt signaling pathway.

One of the most promising strategies for targeting PKA is the use of small molecules that can inhibit the activity of PKA. Small molecules that inhibit the activity of PKA have been shown to be effective in a variety of cancer therapies, including inhibiting the activity of PKA in combination with traditional cancer therapies.

Another approach to targeting PKA is the use of antibodies that can specifically bind to and inhibit the activity of PKA. Monoclonal antibodies (MCAs) have been shown to be effective in targeting PKA and have been used in various clinical trials to treat various diseases, including cancer.

PKA also has a potential as a biomarker for cancer. The expression of PKA has been shown to be overexpressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, the activity of PKA has been shown to be involved in the regulation of cancer cell survival and the regulation of cancer cell-to-cell interactions.

Conclusion

In conclusion, PKA is a protein that plays a crucial role in cellular signaling and has been implicated in various diseases, including cancer. The potential of PKA as a drug target is high, as it has been shown to be involved in the regulation of cell proliferation and the regulation of pain perception and neurodegenerative diseases. Additionally, PKA has

Protein Name: CAMP-Dependent Protein Kinase (PKA)

The "cAMP-Dependent protein kinase (PKA) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about cAMP-Dependent protein kinase (PKA) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets